Injectable chemotherapy vs capecitabine: Preference in Brazilian patients

被引：0
|
作者：
Boscatti, F. H. G. [1 ]
机构：
[1] Prod Roche Quim & Farmaceut SA, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70257-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A78 / A79
页数：2
相关论文
共 50 条
  • [1] Oral vs injectable treatments: Patient preference in Brazilian patients
    Boscatti, F. H. G.
    VALUE IN HEALTH, 2008, 11 (03) : A267 - A267
  • [2] ATTRIBUTES ASSOCIATED WITH A PREFERENCE FOR MONTHLY INJECTABLE THERAPY IN PATIENTS WITH SCHIZOPHRENIA
    Dudash, K.
    Panish, J. M.
    Gupta, S.
    Durkin, M.
    VALUE IN HEALTH, 2012, 15 (04) : A91 - A91
  • [3] Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
    Zhang, Minmin
    Wei, Wei
    Liu, Jianlun
    Yang, Huawei
    Jiang, Yi
    Tang, Wei
    Li, Qiuyun
    Liao, Xiaoming
    ONCOTARGETS AND THERAPY, 2016, 9 : 3443 - 3450
  • [4] RETROSPECTIVE REVIEW OF CHEMORADIATION THERAPY PREFERENCE PATTERNS IN PATIENTS WITH ADVANCED OROPHARYNGEAL CANCER PATIENTS: CETUXIMAB VS CYTOTOXIC CHEMOTHERAPY
    Goldsmith, Tessa
    Huckabee, M.
    DYSPHAGIA, 2009, 24 (04) : 465 - 465
  • [5] Meta-analysis of capecitabine-based chemotherapy versus capecitabine-free chemotherapy in patients with metastatic breast cancer
    Zuo, Li
    Li, Gang
    Xu, Yingchun
    Zhang, Fengchun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 18808 - 18815
  • [6] Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer
    Gursoy, Pinar
    Surmeli, Zeki Gokhan
    Cakar, Burcu
    Arslan, Cagatay
    Zengel, Baha
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
    Schmoll, H. J.
    Stein, A.
    Hofheinz, R. D.
    Price, T. J.
    Nordlinger, B.
    Daisne, J-F.
    Daisne, J-F.
    Janssens, J.
    Brenner, B.
    Schmidt, P.
    Reinel, H.
    Hollerbach, S.
    Caca, K.
    Fauth, F.
    Zalcberg, J.
    Marreaud, S.
    Mauer, M.
    Lutz, M.
    Van Cutsem, E.
    Haustermans, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
    Stein, A.
    Schmoll, H. -J
    Hofheinz, R. D.
    Price, T.
    Nordlinger, B.
    Daisne, J-F
    Janssens, J.
    Brenner, B.
    Schmidt, P.
    Reinel, H.
    Hollerbach, S.
    Caca, K.
    Fauth, F. W. B.
    Hannig, C.
    Zalcberg, J. R.
    Marreaud, S.
    Tebbutt, N. C.
    Mauer, M. E.
    Lutz, M. P.
    Van Cutsem, E.
    Haustermans, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 197 - 197
  • [9] Medication Adherence in Colorectal Cancer Patients With Adjuvant Capecitabine Chemotherapy
    Nagamatsu, Yuki
    Toyofuku, Kayo
    Satoh, Minoru
    Kikuta, Shiho
    Miyazono, Mami
    Chishaki, Akiko
    CANCER NURSING, 2016, 39 : S79 - S80
  • [10] CAPECITABINE AND IRINOTECAN AS FIRSTLINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2010, 16 (03): : 74 - 77
12345